HINOVA Trademark
Trademark Overview
On Thursday, January 18, 2024, a trademark application was filed for HINOVA with the United States Patent and Trademark Office. The USPTO has given the HINOVA trademark a serial number of 98364705. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Wednesday, November 20, 2024. This trademark is owned by Hinova Pharmaceuticals Inc.. The HINOVA trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:
Pharmaceuticals, namely, pharmaceutical preparations and pharmaceutical products for treatment of cancers, hyperuricemia associated disorders and conditions, immune disorders and conditions, neural disorders, metabolic disorders, viral infections, cardiovascular disorders and conditions, and skin disorder and conditions
Medical devices, namely, devices for diagnosis and treatment of cancers, hyperuricemia associated disorders and conditions, immune disorder and conditions, neural disorders, metabolic disorders, viral infections, cardiovascular disorders and conditions, and skin disorder and conditions
General Information
| Serial Number | 98364705 |
| Word Mark | HINOVA |
| Filing Date | Thursday, January 18, 2024 |
| Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
| Status Date | Wednesday, November 20, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Description of Mark | The mark consists of The mark consists of the name Hinova with an arc extending from the top of the "i". |
| Goods and Services | Pharmaceuticals, namely, pharmaceutical preparations and pharmaceutical products for treatment of cancers, hyperuricemia associated disorders and conditions, immune disorders and conditions, neural disorders, metabolic disorders, viral infections, cardiovascular disorders and conditions, and skin disorder and conditions |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | Medical devices, namely, devices for diagnosis and treatment of cancers, hyperuricemia associated disorders and conditions, immune disorder and conditions, neural disorders, metabolic disorders, viral infections, cardiovascular disorders and conditions, and skin disorder and conditions |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, January 18, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, January 18, 2024 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Hinova Pharmaceuticals Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Chengdu, Sichuan 610041
CN |
Trademark Events
| Event Date | Event Description |
| Thursday, January 18, 2024 | NEW APPLICATION ENTERED |
| Friday, May 24, 2024 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Friday, May 24, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, August 21, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, August 21, 2024 | NON-FINAL ACTION WRITTEN |
| Wednesday, August 21, 2024 | NON-FINAL ACTION E-MAILED |
| Wednesday, November 20, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, November 20, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, November 20, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, August 14, 2024 | ASSIGNED TO EXAMINER |
